C4 Therapeutics (CCCC) Earnings Date, Estimates & Call Transcripts $1.60 -0.03 (-1.84%) (As of 12/1/2023 ET) Add Compare Share Share Today's Range$1.47▼$1.6050-Day Range$1.32▼$1.9952-Week Range$1.23▼$9.41Volume304,676 shsAverage Volume300,527 shsMarket Capitalization$78.85 millionP/E RatioN/ADividend YieldN/APrice Target$9.33 EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateFeb. 22EstimatedActual EPS (Nov. 1) -$0.55 Beat By $0.10 Consensus EPS (Nov. 1) -$0.65 Get C4 Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for CCCC and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueCCCC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CCCC Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. C4 Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20232($0.75)($0.71)($0.73)Q2 20231($0.81)($0.81)($0.81)Q3 20232($0.87)($0.71)($0.79)Q4 20233($0.79)($0.58)($0.69)FY 20238($3.22)($2.81)($3.02)CCCC Earnings Date and InformationC4 Therapeutics last released its earnings results on November 1st, 2023. The reported ($0.55) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.65) by $0.10. The company had revenue of $11.07 million for the quarter, compared to the consensus estimate of $6.94 million. C4 Therapeutics has generated ($2.75) earnings per share over the last year (($2.75) diluted earnings per share). Earnings for C4 Therapeutics are expected to decrease in the coming year, from ($2.53) to ($2.59) per share. C4 Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 22nd, 2024 based off prior year's report dates.Read More C4 Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 2/22/2024Estimated)------- 11/1/2023Q3 2023($0.65)($0.55)+$0.10($0.55)$6.94 million$11.07 million8/8/2023Q2 2023($0.74)($0.73)+$0.01($0.73)$8.65 million$2.66 million5/4/2023Q1 2023($0.78)($0.71)+$0.07($0.71)$6.71 million$3.76 million2/23/2023Q4 2022($0.72)($0.76)($0.04)($0.76)$8.56 million$2.85 million11/3/2022Q3 2022($0.65)($0.65)-($0.65)$9.72 million$6.75 million8/4/2022Q2 2022($0.68)($0.56)+$0.12($0.56)$7.79 million$13.83 million Get the Latest News and Ratings for CCCC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for C4 Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/5/2022Q1 2022($0.61)($0.65)($0.04)($0.65)$7.67 million$7.65 million2/24/2022Q4 2021($0.59)($0.31)+$0.28($0.31)$7.16 million$20.08 million 11/10/2021Q3 2021($0.57)($0.51)+$0.06($0.51)$7.28 million$8.50 million8/10/2021Q2 2021($0.59)($0.51)+$0.08($0.51)$7.45 million$9.78 million5/13/2021Q1 2021($0.63)($0.49)+$0.14($0.49)-$7.43 million C4 Therapeutics Earnings - Frequently Asked Questions When is C4 Therapeutics's earnings date? C4 Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 22nd, 2024 based off last year's report dates. Learn more on CCCC's earnings history. Did C4 Therapeutics beat their earnings estimates last quarter? In the previous quarter, C4 Therapeutics (NASDAQ:CCCC) reported ($0.55) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.65) by $0.10. Learn more on analysts' earnings estimate vs. CCCC's actual earnings. How much revenue does C4 Therapeutics generate each year? C4 Therapeutics (NASDAQ:CCCC) has a recorded annual revenue of $31.10 million. How much profit does C4 Therapeutics generate each year? C4 Therapeutics (NASDAQ:CCCC) has a recorded net income of -$128.18 million. CCCC has generated -$2.75 earnings per share over the last four quarters. What is C4 Therapeutics's EPS forecast for next year? C4 Therapeutics's earnings are expected to decrease from ($2.53) per share to ($2.59) per share in the next year. More Earnings Resources from MarketBeat Related Companies: TPST Earnings Date BCAB Earnings Date IKNA Earnings Date KRON Earnings Date ACRV Earnings Date SYRS Earnings Date ADVM Earnings Date VTGN Earnings Date RLMD Earnings Date TSBX Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Earnings propel Crowdstrike, cybersecurity sector, to new highsAlibaba is down more than 10% since earnings, now what?2 stocks that faded their price gaps after crushing earnings Hims & Hers earnings highlight expanded personalized treatmentsCan Kohl's keep its momentum after earnings dip?Nvidia's earnings, dominance, growth and global challenges$20 looks like a good fit for The Gap after XL earnings beat This page (NASDAQ:CCCC) was last updated on 12/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding C4 Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.